KWELLS hyoscine hydrobromide 0.3mg chewable tablet blister pack (new formulation)

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

hyoscine hydrobromide, Quantity: 300 microgram

Disponibbli minn:

iNova Pharmaceuticals (Australia) Pty Ltd

INN (Isem Internazzjonali):

Hyoscine hydrobromide

Għamla farmaċewtika:

Tablet, chewable

Kompożizzjoni:

Excipient Ingredients: saccharin sodium; iron oxide red; aluminium stearate; Gelatin; mannitol; potato starch

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

12

Tip ta 'preskrizzjoni:

(S2) Pharmacy Medicine

Indikazzjonijiet terapewtiċi:

For the prevention of travel sickness

Sommarju tal-prodott:

Visual Identification: Small pink circular flat faced tablet with bevelled edges and a single break bar on one side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2013-07-16